CD274 and neoplasm: Although the PD-L1 expression levels in SCLC tumor tissues are yet to be recognized as a predictive marker for ICI 38, we believe that such a biomarker together or not with genomic mutations in SCLC tissues could be primarily evaluated using EBUS-TBNA specimens, which are easier to collect.